Enter to open, tab to navigate, enter to select
NeoGenomics, Inc. acquisition of stock of Clarient, Inc.
| October 20, 2015 • Private Acquisition Agreements • $275.2 million (approximate deal value based on price of Buyer Guarantor common stock on signing date and press release; subject to purchase price adjustment). |
End of Document
© 2024 Thomson Reuters. No claim to original U.S. Government Works.